Pharmaceuticals
Price
$24.32
+1.84%Market Cap
$138.61B
Day High
$24.57
Day Low
$24.13
Pfizer reported Q1 2026 revenue of $14.45B (+5.4% YoY), but net income declined 9.4% to $2.69B as cost of revenue surged 24.7%, compressing margins despite improved operating cash flow of $2.62B.
Key risk: Margin Compression from Rising Cost of Revenue
Cost of revenue grew at 24.7% YoY, nearly five times the revenue growth rate of 5.4%, driving net margin down to 18.6% from approximately 21.6% in the prior year period. If this cost trend persists, it could materially erode Pfizer's profitability even as top-line growth continues.
Other Pharmaceuticals companies